Trump made the announcement in the Oval Office alongside Gilead CEO Daniel O’Day.
“We want to thank the collaborators that brought remdesivir to this point and many of our people that have been part of this, in fact, the caregivers,” O’Day said.
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, which conducted the trials, has called the quick development of the drug “very important.”
Having a treatment could have a profound effect because health officials say any vaccine typically takes a year or more to develop and bring to market safely.
Previously the FDA authorized the emergency use of malaria drugs chloroquine and hydroxychloroquine to treat the virus, but followed up with warnings against taking the drugs outside a hospital because of its potential to cause heart rhythm problems.
Remdesivir is given through an IV and is designed to interfere with an enzyme that reproduces viral genetic material.
— This is a developing story. Please return to AJC.com for updates.